Testosterone in 2026: The Research Just Got More Complicated, and That's Good News for Men
Something unusual happened in men's health this year. The evidence on testosterone got better and more complicated at the same time — and the combination undercuts both camps in the argument.
If you've been following the "low T" conversation, here's where it actually stands.
First, the reassurance
The TRAVERSE trial randomized more than 5,200 men aged 45–80 with documented hypogonadism and elevated cardiovascular risk to testosterone gel or placebo, followed for a median of roughly 22 months. The primary outcome — cardiovascular death, heart attack or stroke — came in at 7.0% in the testosterone group, meeting non-inferiority.
That settled a question that had hung over the field for a decade. In 2025, the FDA removed the boxed cardiovascular warning from testosterone labels, while adding a blood-pressure warning.
For men with genuine, properly diagnosed hypogonadism, that's meaningful. Treatment that works, with the main cardiovascular fear addressed.
Then, the complication
Early 2026 produced a finding running in the opposite direction.
A Mendelian randomization study found that men with genetically higher lifelong testosterone have about a 17% higher risk of coronary artery disease, likely partly via higher blood pressure.
And an earlier analysis of genetic testosterone data from over 167,000 men found that genetically higher testosterone was associated with shorter survival.
So which is it?
Both, and the distinction matters
An accompanying editorial in JCEM made the key point: Mendelian randomization of endogenous testosterone is not the same thing as exogenous TRT in carefully treated hypogonadal men.
These studies are answering different questions.
TRAVERSE asks: if a man is genuinely deficient and symptomatic, does correcting him to a normal range hurt his heart? Answer: apparently not.
The Mendelian randomization asks: does running naturally high testosterone across an entire lifetime carry cardiovascular cost? Answer: apparently a modest one.
Neither result says "more testosterone is better." Both say something more useful: the goal is an appropriate level, not a maximal one.
Why this matters for how men approach it
The clinical field has moved with it. Clinicians in 2026 are less focused on hitting a single testosterone number and more focused on what declining hormones actually do to the systems that determine healthspan: metabolic function, muscle maintenance, cardiovascular health, cognitive performance, sleep quality, and sexual function.
That's a different question from "what's my number?" — and a considerably better one.
Because the mechanisms run both directions. Low testosterone is associated with increased visceral fat, insulin resistance, reduced muscle protein synthesis, and elevated inflammatory markers. But visceral fat also produces low testosterone, because adipose tissue contains aromatase, the enzyme converting testosterone into estrogen.
Belly fat doesn't merely accompany low testosterone. It manufactures it.
The variable men skip
Here's the finding that should be on every clinic wall.
One week of sub-5-hour sleep reduces testosterone by 10–15% in healthy young men.
Young men. One week. Not a supplement question — a sleep question. The majority of a man's daily testosterone release occurs during sleep, and chronically elevated cortisol from long-term stress compounds it.
So before a man concludes his endocrine system is failing, three things deserve an honest audit: sleep duration and quality, alcohol intake, and visceral fat. All three suppress testosterone directly. All three are free to address. And all three are usually running in the background of a man's "low T" result without anyone naming them.
The sequence that actually makes sense
This is where Dr. John Spencer Ellis has been consistent, and it's worth stating plainly because it gets misread in both directions.
He is not anti-TRT. For men with properly diagnosed hypogonadism, testosterone therapy is legitimate, effective and now considerably better supported than it was five years ago. Men who need it should have it.
The argument is about sequence. Before committing to a lifelong therapy that suppresses your own production, find out whether your system is actually failing or merely suppressed — because six broken hours of sleep, four drinks a night and thirty pounds of visceral fat will produce a low number in a man whose endocrine system is entirely intact.
Ninety days of correcting those three tells you something a single blood test cannot.
If the number rises and the symptoms resolve, you were functionally suppressed and you've avoided a therapy you didn't need. If it doesn't, you're now a far better candidate than you were in month one — with the reversible factors already corrected and a cleaner clinical picture for your physician.
How to test it properly
Morning draw, fasted, two separate occasions at least 48 hours apart, with symptoms documented. And ask specifically for LH and FSH, which distinguish a testicular problem from a pituitary one. Direct-to-consumer panels routinely omit them, and they change the diagnosis.
Also screen for sleep apnea if you snore or wake unrefreshed. It's common in men over 40, treatable, independently associated with reduced testosterone, and diagnosed in a fraction of the men who have it.
Where coaching fits
Dr. Ellis' Health, Longevity and Aesthetic Optimization Program for Men 40+ is built around exactly this ninety-day diagnostic window: comprehensive intake covering sleep, stress load, alcohol and medications; bloodwork guidance alongside your own physician so you request the right panel under the right conditions; resistance training and visceral fat reduction programmed properly; and twelve weekly one-on-one sessions.
The point isn't to talk anyone out of treatment. It's to make sure the man walking into that appointment has already cleared the confounders — so whatever his physician decides is based on his actual endocrine function rather than his last eighteen months of sleep debt.
When the obstacle is a schedule that makes sleep and training impossible, the Escape the Rat Race Coaching Program addresses that structurally instead.
Book a free initial evaluation — no cost, no obligation.
Educational content, not medical advice. Testosterone therapy decisions belong with a qualified physician.
